These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32873214)

  • 1. Dry powder inhalers: a concise summary of the electronic monitoring devices.
    Mehta PP
    Ther Deliv; 2021 Jan; 12(1):1-6. PubMed ID: 32873214
    [No Abstract]   [Full Text] [Related]  

  • 2. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.
    Ninane V; Vandevoorde J; Cataldo D; Derom E; Liistro G; Munghen E; Peché R; Schlesser M; Verleden G; Vincken W
    Respir Med; 2015 Nov; 109(11):1430-8. PubMed ID: 26439177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
    van der Palen J; Thomas M; Chrystyn H; Sharma RK; van der Valk PD; Goosens M; Wilkinson T; Stonham C; Chauhan AJ; Imber V; Zhu CQ; Svedsater H; Barnes NC
    NPJ Prim Care Respir Med; 2016 Nov; 26():16079. PubMed ID: 27883002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance Characteristics of Breezhaler
    Molimard M; Kottakis I; Jauernig J; Lederhilger S; Nikolaev I
    Clin Drug Investig; 2021 May; 41(5):415-424. PubMed ID: 33768480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany.
    Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P
    Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol Delivery Devices for Obstructive Lung Diseases.
    Pleasants RA; Hess DR
    Respir Care; 2018 Jun; 63(6):708-733. PubMed ID: 29794206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
    Pepper AN; Cooke A; Livingston L; Lockey RF
    Allergy Asthma Proc; 2016 Jul; 37(4):279-90. PubMed ID: 27401315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison Among Different Inhalers in COPD: The Differences Are Too Big and Too Small, and It Matters.
    Blagev DP
    Chest; 2023 Apr; 163(4):731-732. PubMed ID: 37031973
    [No Abstract]   [Full Text] [Related]  

  • 10. The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers.
    Weers J; Clark A
    Pharm Res; 2017 Mar; 34(3):507-528. PubMed ID: 27738953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.
    Serra-Batlles J; Plaza V; Badiola C; Morejón E;
    J Aerosol Med; 2002; 15(1):59-64. PubMed ID: 12006146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative evaluation of adherence and inhalation technique among respiratory patients: An observational study using an electronic inhaler assessment device.
    Hesso I; Nabhani Gebara S; Greene G; Co Stello RW; Kayyali R
    Int J Clin Pract; 2020 Feb; 74(2):e13437. PubMed ID: 31621983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease.
    Prenner BM
    Expert Opin Pharmacother; 2007 Dec; 8(17):3069-84. PubMed ID: 18001266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing drug delivery in COPD: The role of inhaler devices.
    Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
    Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry powder inhalers - between the doctor and the patient.
    Emeryk A; Pirożyński M; Emeryk-Maksymiuk J
    Adv Respir Med; 2018; 86(1):44-52. PubMed ID: 29490421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers.
    Boshra MS; Almeldien AG; Salah Eldin R; Elberry AA; Abdelwahab NS; Nabil Salem M; Rabea H; Abdelrahim MEA
    Exp Lung Res; 2018; 44(4-5):211-216. PubMed ID: 30346848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
    Zervas E; Samitas K; Gaga M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Cavalli F; Usmani OS; Rogliani P
    Expert Opin Drug Deliv; 2020 May; 17(5):635-646. PubMed ID: 32130023
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of pharmacists' attitudes towards interchangeable use of dry powder inhalers.
    Williams AE; Chrystyn H
    Pharm World Sci; 2007 Jun; 29(3):221-7. PubMed ID: 17242855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.